Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
Boros E, Ertl DA, Berkenou J, Audrain C, Lecoq AL, Kamenicky P, Briot K, Amouroux C, Zhukouskaya V, Gueorguieva I, Mignot B, Girerd B, Porquet Bordes V, Salles JP, Edouard T, Coutant R, Bacchetta J, Linglart A, Rothenbuhler A. Boros E, et al. Among authors: audrain c. Eur J Endocrinol. 2023 Oct 17;189(4):469-475. doi: 10.1093/ejendo/lvad144. Eur J Endocrinol. 2023. PMID: 37831782
Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia.
Zhukouskaya VV, Mannes I, Chaussain C, Kamenický P, Audrain C, Lambert AS, Nevoux J, Wicart P, Briot K, Di Rocco F, Trabado S, Prié D, Di Somma C, Colao A, Adamsbaum C, Rothenbuhler A, Linglart A. Zhukouskaya VV, et al. Among authors: audrain c. Eur J Endocrinol. 2021 Aug 27;185(4):475-484. doi: 10.1530/EJE-21-0429. Eur J Endocrinol. 2021. PMID: 34292170 Clinical Trial.
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
Ertl DA, de Nanclares GP, Jüppner H, Hanna P, Pagnano A, Pereda A, Rothenbuhler A, Del Sindaco G, Ruiz-Cuevas P, Audrain C, Escribano A, Berkenou J, Gleiss A, Mantovani G, Linglart A. Ertl DA, et al. Among authors: audrain c. Eur J Endocrinol. 2023 Jul 20;189(1):123-131. doi: 10.1093/ejendo/lvad085. Eur J Endocrinol. 2023. PMID: 37440712 Free PMC article.
Young XLH Patients-Reported Experience with a Supportive Care Program.
Rothenbuhler A, Gueorguieva I, Lichtenberger-Geslin L, Audrain C, Soskin S, Bensignor C, Rossignol S, Bertholet-Thomas A, Naudeau L, Bacchetta J, Linglart A. Rothenbuhler A, et al. Among authors: audrain c. Patient Prefer Adherence. 2023 Jun 9;17:1393-1405. doi: 10.2147/PPA.S391025. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37325587 Free PMC article.
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.
Ertl DA, Mantovani G, de Nanclares GP, Elli FM, Pereda A, Pagnano A, Sanchis A, Cueto-Gonzalez AM, Berrade S, León MC, Rothenbuhler A, Audrain C, Berkenou J, Knight N, Dolman K, Gleiss A, Argente J, Linglart A. Ertl DA, et al. Among authors: audrain c. J Endocrinol Invest. 2023 Aug;46(8):1673-1684. doi: 10.1007/s40618-023-02026-2. Epub 2023 Feb 7. J Endocrinol Invest. 2023. PMID: 36749450
23 results